Trending
- South Africa cannot afford to lag while youth nicotine addiction escalates
- Evicted Durban tenants win urgent court order pending eviction challenge
- Pension fund withdrawal benefits are determined by rules, not contributions
- Teachers win compensation after decade of rolling contracts ruled unlawful
- Tshwane loses land expropriation battle, ordered to relocate Kanana Village residents
- Sportscene lawyers ordered to pay costs after appeal delayed by flawed court record
- Do South Africa’s archives serve justice or preserve historical injustice?
- Turning your home into student accommodation could cost landlords dearly
Author: Professor Theresa Rossouw
Professor Theresa Rossouw
Department of Immunology at the University of Pretoria (UP). An NRF-rated scientist who mainly works in the field of HIV and related infections, where she is specifically interested in HIV-associated drug resistance and systemic immune activation.
Prof Theresa Rossouw writes that the launch of the BRILLIANT 011 study is not a breakthrough moment, but, “an important step in a long and complex scientific process,” urging cautious optimism as South Africa advances its HIV prevention efforts.